A Levine

3.7k total citations
45 papers, 2.7k citations indexed

About

A Levine is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, A Levine has authored 45 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Pathology and Forensic Medicine and 13 papers in Genetics. Recurrent topics in A Levine's work include Lymphoma Diagnosis and Treatment (15 papers), Viral-associated cancers and disorders (14 papers) and Chronic Lymphocytic Leukemia Research (12 papers). A Levine is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Viral-associated cancers and disorders (14 papers) and Chronic Lymphocytic Leukemia Research (12 papers). A Levine collaborates with scholars based in United States, Singapore and Nigeria. A Levine's co-authors include Jean L. Richardson, Anil Tulpule, Mark Krailo, Joel M. Palefsky, Gary Marks, Sandra Melnick, Robert D. Burk, Howard Minkoff, Henry S. Sacks and Parkash S. Gill and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

A Levine

43 papers receiving 2.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
A Levine 1.3k 849 705 486 417 45 2.7k
David M. Aboulafia 2.3k 1.8× 1.1k 1.3× 1.2k 1.8× 859 1.8× 598 1.4× 174 4.3k
Marina T. van Leeuwen 2.5k 1.9× 1.4k 1.6× 611 0.9× 1.1k 2.2× 291 0.7× 51 4.1k
Aziza Shad 640 0.5× 526 0.6× 405 0.6× 114 0.2× 602 1.4× 48 2.7k
Thomas H. Taylor 1.0k 0.8× 411 0.5× 401 0.6× 503 1.0× 84 0.2× 87 2.6k
Hal B. Jenson 1.5k 1.2× 870 1.0× 604 0.9× 181 0.4× 785 1.9× 95 2.5k
Caroline H. Shiboski 717 0.6× 751 0.9× 555 0.8× 1.3k 2.7× 288 0.7× 78 5.2k
Misha Rosenbach 439 0.3× 1.4k 1.6× 590 0.8× 523 1.1× 828 2.0× 204 4.2k
Rafael F. Duarte 1.8k 1.5× 1.3k 1.5× 539 0.8× 224 0.5× 963 2.3× 163 6.1k
Joseph Rosenthal 742 0.6× 805 0.9× 201 0.3× 250 0.5× 127 0.3× 139 3.6k
Montserrat Rovira 2.1k 1.6× 1.9k 2.2× 731 1.0× 412 0.8× 1.1k 2.6× 218 6.7k

Countries citing papers authored by A Levine

Since Specialization
Citations

This map shows the geographic impact of A Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Levine more than expected).

Fields of papers citing papers by A Levine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Levine. The network helps show where A Levine may publish in the future.

Co-authorship network of co-authors of A Levine

This figure shows the co-authorship network connecting the top 25 collaborators of A Levine. A scholar is included among the top collaborators of A Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Levine. A Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fayette, Jérôme, Gerald A. Thomas, Amaury Daste, et al.. (2024). 853MO Setanaxib plus pembrolizumab for the treatment of recurrent or metastatic squamous cell carcinoma of the head & neck: Results of a randomized, double-blind phase II trial. Annals of Oncology. 35. S615–S616. 4 indexed citations
2.
Villacres, Maria C., Naoko Kono, Wendy J. Mack, et al.. (2012). Interleukin 10 Responses Are Associated With Sustained CD4 T-Cell Counts in Treated HIV Infection. The Journal of Infectious Diseases. 206(5). 780–789. 13 indexed citations
3.
Lim, Soon Thye & A Levine. (2005). Recent Advances in Acquired Immunodeficiency Syndrome (AIDS)-related Lymphoma. CA A Cancer Journal for Clinicians. 55(4). 229–241. 40 indexed citations
4.
Volberding, Paul A., A Levine, Douglas T. Dieterich, et al.. (2004). Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies. Clinical Infectious Diseases. 38(10). 1454–1463. 192 indexed citations
5.
Lekawanvijit, Suree, et al.. (2003). Different Localization of Dendritic Cell Reservoirs in Human Immunodeficiency Virus-1 Subtype B Versus Subtype E-infected Lymph Nodes. Applied immunohistochemistry & molecular morphology. 11(2). 144–148. 5 indexed citations
6.
Strickler, Howard D., Joel M. Palefsky, K. V. Shah, et al.. (2003). Human Papillomavirus Type 16 and Immune Status in Human Immunodeficiency Virus-Seropositive Women. JNCI Journal of the National Cancer Institute. 95(14). 1062–1071. 177 indexed citations
7.
Hilton, Joan F., Mario E.A.F. Alves, Kathryn Anastos, et al.. (2001). Accuracy of diagnoses of HIV-related oral lesions by medical clinicians. Findings from the Women's Interagency HIV Study. Community Dentistry And Oral Epidemiology. 29(5). 362–372. 9 indexed citations
8.
Rarick, Mark U., Jonathan E. Kolitz, Jack Bernstein, et al.. (2001). Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin’s lymphoma. Annals of Oncology. 12(4). 457–462. 15 indexed citations
9.
10.
Palefsky, Joel M., Howard Minkoff, Leslie A. Kalish, et al.. (1999). Cervicovaginal Human Papillomavirus Infection in Human Immunodeficiency Virus-1 (HIV)-Positive and High-Risk HIV-Negative Women. JNCI Journal of the National Cancer Institute. 91(3). 226–236. 409 indexed citations
11.
Tulpule, Anil & A Levine. (1999). AIDS-related lymphoma. Blood Reviews. 13(3). 147–150. 61 indexed citations
12.
Telzak, Edward E., Ronald C. Hershow, Leslie A. Kalish, et al.. (1998). Seroprevalence of HTLV-I and HTLV-II Among a Cohort of HIV-Infected Women and Women at Risk for HIV Infection. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 19(5). 513–518. 9 indexed citations
13.
14.
Douer, Dan, Laleh Ramezani, Ann Mohrbacher, et al.. (1998). The Influence of Patient-Related Factors on Ex Vivo Retroviral-Mediated Gene Transfer into Mobilized Peripheral Blood Myeloid Progenitors. Human Gene Therapy. 9(7). 1061–1068. 2 indexed citations
15.
Gill, Parkash S., Byron M. Espina, Franco M. Muggia, et al.. (1995). Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.. Journal of Clinical Oncology. 13(4). 996–1003. 182 indexed citations
16.
Masood, R., Yanto Lunardi-Iskandar, Tarsem Moudgil, et al.. (1994). IL-10 Inhibits HIV-1 Replication and Is Induced by Tat. Biochemical and Biophysical Research Communications. 202(1). 374–383. 61 indexed citations
17.
Williams, Christopher K., S Alexander, Anne J. Bodner, et al.. (1993). Frequency of adult T-cell leukaemia/lymphoma and HTLV-I in Ibadan, Nigeria. British Journal of Cancer. 67(4). 783–786. 14 indexed citations
18.
Richardson, Jean L., et al.. (1990). The effect of compliance with treatment on survival among patients with hematologic malignancies.. Journal of Clinical Oncology. 8(2). 356–364. 227 indexed citations
19.
Rarick, Mark U., et al.. (1990). Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine. Annals of Oncology. 1(2). 147–149. 18 indexed citations
20.
Levine, A. (1988). Management of the patient with large cell lymphoma. Blood Reviews. 2(2). 71–77. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David M. Aboulafia Breakdown of academic impact, for papers by Marina T. van Leeuwen Breakdown of academic impact, for papers by Aziza Shad Breakdown of academic impact, for papers by Thomas H. Taylor Breakdown of academic impact, for papers by Hal B. Jenson Breakdown of academic impact, for papers by Caroline H. Shiboski Breakdown of academic impact, for papers by Misha Rosenbach Breakdown of academic impact, for papers by Rafael F. Duarte Breakdown of academic impact, for papers by Joseph Rosenthal Breakdown of academic impact, for papers by Montserrat Rovira
Rankless by CCL
2026